期刊
CEPHALALGIA
卷 28, 期 7, 页码 683-688出版社
SAGE PUBLICATIONS LTD
DOI: 10.1111/j.1468-2982.2008.01600.x
关键词
migraine; adverse events; assessment; reporting
Tolerability of a drug should be regarded as important as its efficacy. In all four phases of drug development evaluation of adverse events is important. Recommendations for assessment of adverse events in acute and prophylactic clinical drug trials in migraine are given. Tolerability may be indirectly assessed using measures of general well-being and eight such tools are presented. Finally, recommendations for reporting of adverse events are given.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据